Low Dose Azathioprine with Allopurinol in IBD: Early Days to Call It a Recipe for Success
- PMID: 35244826
- DOI: 10.1007/s10620-021-07375-7
Low Dose Azathioprine with Allopurinol in IBD: Early Days to Call It a Recipe for Success
Comment on
-
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases.Dig Dis Sci. 2022 Aug;67(8):4008-4019. doi: 10.1007/s10620-021-07273-y. Epub 2021 Nov 2. Dig Dis Sci. 2022. PMID: 34729677 Free PMC article.
References
-
- Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:S1–S106. - DOI
-
- Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Eng J Med. 2010;362:1383–1395. - DOI
-
- van Liere ELSA, Bayoumy AB, Mulder CJJ, Warner B, Hayee B, Mateen BA, et al. Azathioprine with allopurinol is a promising first-line therapy for inflammatory bowel diseases. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-021-07273-y .
-
- Rosenberg L, Lawlor GO, Zenlea T, Goldsmith JD, Gifford A, Falchuk KR, et al. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis. 2013;19:779–784. - DOI
-
- Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–1338. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous